(Reuters) – Merck Co Inc reported better-than-expected quarterly earnings despite the negative impact of the stronger dollar, with solid sales growth from its vaccines and treatments for diabetes and HIV. The No. 2 U.S. drugmaker said on Friday it earned $1.79 billion, or 58 cents per share, in the second quarter. That …
Related posts:
YouTube launches new face-blurring feature to disguise identities
Sombart
Earthquake strikes central Australia
Jonas Armstrong: Robin Hood actor sentenced to charity shop work after being caught drink-driving
Pepsi Digital Exec: Google 'Messed Up' With Google+, Instagram Is 'Phenomenal'
What You May Not Know About Sunscreen... Skin Cancer!
Views: 0